Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Primary Care

Journal Scan / Research · May 10, 2023

Durability of Neutralizing RSV Antibodies Following Nirsevimab Administration and Elicitation of the Natural Immune Response to RSV Infection in Infants

Nature Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

Nature Medicine
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants
Nat. Med. 2023 Apr 24;[EPub Ahead of Print], D Wilkins, Y Yuan, Y Chang, AA Aksyuk, BS Núñez, U Wählby-Hamrén, T Zhang, ME Abram, A Leach, T Villafana, MT Esser

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading